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Abstract 
Rationale 
Rapid response by health-care systems for transient ischaemic attack and minor stroke 
(TIA/mS) is recommended to maximize the impact of secondary prevention strategies. The 
applicability of this evidence to Australian non-hospital-based TIA/mS management is 
uncertain.  
Aims 
Within an Australian community setting we seek to document processes of care, establish 
determinants of access to care, establish attack rates and determinants of recurrent vascular 
events and other clinical outcomes, establish the performance of ABC2-risk stratification, 
and compare processes of care and outcomes to those in the UK and New Zealand for 
TIA/mS. 
Sample size estimates 
Recruiting practices containing approximately 51 full-time-equivalent general practitioners to 
recruit 100 TIA/mS per year over a 4-year study period will provide sufficient power for each 
of our outcomes 
Methods and design 
An inception cohort study of patients with possible TIA/mS recruited from 16 general 
practices in the Newcastle-Hunter Valley-Manning Valley region of Australia. Potential 
TIA/mS will be ascertained by multiple overlapping methods at general practices, after-hours 
collaborative, and hospital in-patient and outpatient services. Participants’ index and 
subsequent clinical events will be adjudicated as TIA/mS or mimics by an expert panel. 
Study outcomes 
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Process outcomes: whether the patient was referred for secondary care; time from event to 
first patient presentation to a health professional; time from event to specialist acute-access 
clinic appointment; time from event to brain and vascular imaging and relevant prescriptions  
Clinical outcomes: recurrent stroke and major vascular events; and Health-Related Quality of 
Life.   
Discussion 
Community management of TIA/mS will be informed by this study. 
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Introduction and rationale 
Transient ischaemic attack and minor stroke (TIA/mS) comprise approximately 40% of all 
episodes of brain ischaemia1,2 and carry a significant risk of disabling or fatal stroke.3 Much 
of the stroke risk occurs very early after TIA/mS4 and rapid specialist assessment and 
intervention has been shown to reduce this risk.5,6 Therefore a rapid response within the 
system of care for TIA/mS is required to maximize the impact of secondary prevention 
strategies.6,7 Based on this international evidence, current Australian guidelines recommend 
universal rapid-access to specialist care.8  
There are uncertainties regarding compliance with these guidelines and with the applicability 
of the current evidence and guidelines to the contemporary management of TIA/mS in 
Australia beyond the hospital secondary care setting.  
Rapid-access acute neurovascular clinics, one preferred model,6 were only available in 38% 
of Australian hospitals in 20159 compared with 98% of UK hospitals 2010.10 Even in 
Australian areas with rapid-access clinics, service utilization is uncertain. Extrapolation of 
figures for populations served11,12 and TIA/mS seen4,13 in acute neurovascular clinics in 
Oxfordshire and the Hunter region of Australia (where TIA/mS are infrequently admitted to 
hospital) suggest that the majority of TIA/mS in this Australian region are not referred for 
rapid-access management. Thus it is not clear if improvements in TIA/mS outcomes evident 
in regions with more ready access to stroke specialist care7 are applicable to health systems 
such as Australia’s.  
There are uncertainties concerning TIA/mS management and compliance with national 
guidelines in Australia. These include:  
1. Contemporary management and processes of care for TIA/mS have not been well 
characterized in Australia nor have they been compared to international benchmarks  
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2. The performance of the Australian health care system in the management of TIA/mS has 
not been examined in sufficient detail to inform or update local guidelines and health policy. 
Variations in models of care, access to stroke specialist diagnostic and management 
support, factors influencing processes of care including resource utilization and comparison 
to the UK-based models (currently an important source of evidence for Australian guidelines) 
have not been evaluated.  
3. The clinical outcomes of TIA/mS have not been defined nor have the guideline-
recommended tools for risk stratification been validated in contemporary Australian 
populations, where geographic access to specialist care can be limited and many elements 
of management need to be undertaken in primary care (contrary to the current Australian 
guideline recommendations8).  
 
The aims of the International comparison of Systems of care and patient outcomes In minor 
Stroke and Tia (InSIST) study are to answer research questions related to these evidence 
gaps. Specifically:  
1. What is the process of care for a prospective cohort of possible TIA/mS patients 
interacting with the Australian primary and secondary care systems? 
2. What are the determinants of access to care? 
3. What are the determinants of recurrent vascular events? 
4. What is the applicability of the internationally derived risk stratification tool ABCD214 to 
management and referral processes in Australia? 
5. How does the process of care for TIA/mS in Australia influence clinical outcomes?  
6. How do processes of care and outcomes for TIA/mS in Australia compare to those in 
the UK and New Zealand? 
Methods 
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Design 
InSIST is an inception cohort study in which patients with possible TIA/mS were followed for 
12 months post-index event. InSIST records patients’ outcomes and their interactions with 
health care systems. 
Patient population 
Participants were recruited from the Hunter and Manning valleys regions of New South 
Wales, within the referral territory of the Acute Neurovascular Clinic (ANVC) at the John 
Hunter Hospital (the major teaching and referral hospital of the Hunter New England Local 
Health District). These patient participants attended one of 16 general practices within the 
Hunter New England and Central Coast Primary Health Network (HNECCPHN). The 
HNECCPHN population includes 18.3% aged 65+ years (compared to 14.4% nationally) and 
has prevalence of diabetes (4.9%) lower than nationally (5.4%) and of circulatory system 
disease (18.5%) higher than nationally (17.3%).15 InSIST recruited urban (11) and rural 
practices (5) – including rural practices (2) in which general practitioners (GPs) staff the local 
hospitals.  
Recruitment, detailing and further engagement of general practices 
Practices were recruited by initial contact with individual GPs, the sampling frame being the 
membership list of the Hunter Medicare Local, a comprehensive list of GPs in the Hunter 
region. Subsequent recruitment processes were adapted to variability in practice size, 
organisation, governance and processes across the region. A requirement of recruitment 
was that the practice assign a practice nurse to work on the study. 
Once a practice agreed to participate in the study, a study investigator (PM) visited the 
practice to orient the designated study practice nurse to the project. The study research 
manager (DQ) then visited the practice to deliver comprehensive study procedures training 
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to the study practice nurse, including ascertainment strategies and data collection 
procedures. 
Awareness of the study and of methods was maintained with regular visits to recruiting 
practices by study investigators (CL, PM, DL) and periodic meetings with participating 
practice nurses where the progress of the study was reviewed, organisational issues 
discussed, and clinical education on recognition of difficult TIA/mS scenarios provided.   
Ascertainment of events and recruitment of patients 
The study aimed to recruit all patients with possible TIA/mS to ensure full case 
ascertainment. All patients where the attending GP considered TIA/mS a possible diagnosis 
were invited to participate. This strategy reflects the ‘real world’ clinical difficulty for GPs in 
distinguishing TIA/mS from mimics16 and evidence that the incidence of transient 
neurological symptoms in the population is substantially greater than the specialist-
diagnosed incidence of TIA in hospital-based and population-based studies.17,18 
Furthermore, there is evidence of variation in the description of TIA/mS features.  Less 
conventional features of presentation are increasingly noted to be important where ‘the 
physical phenotype of stroke that is used as the basis for clinical description of TIA may not 
capture all of the available diagnostic information’.19 
Patients were identified as potential entrants to the study cohort by multiple overlapping 
methods (see Appendix 1). 
Study participant inclusion and exclusion criteria are detailed in Appendix 2 
Recruitment of patients was undertaken from August 2012 to June 2016. Recruitment 
procedures are detailed in Appendix 3 
Data collection 
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As far as possible data collected was harmonised with the Oxford (UK) and Auckland (New 
Zealand) based OXVASC20 and ARCOS21 studies to enable international comparisons of 
systems of care for TIA/mS.  
Participant data 
Participants underwent baseline interview and follow-up interviews at three- and 12-months 
post-baseline assessment.  The interviews were either via phone or home-visit, depending 
on the participant’s functional status.  For details of participant data collected, see Appendix 
4 
Following collection of baseline data, index events were adjudicated as stroke, TIA or a 
TIA/mS mimic.  The adjudication panel consisted of three medical clinicians, at least one of 
which was a stroke physician and at least one of which was a GP.  The adjudication panel 
assessed available information on the participant and on the index event, including the 
participant and witness narratives of events, past medical history/vascular risk factors, 
medications, imaging and other test results, general practice consultation notes, referral 
letters, specialist consultation notes, and emergency department or hospital discharge 
letters.    
The nature of each TIA/mS mimic was adjudicated, as was the territory of the TIA/mS or 
mimic e.g. anterior (cortical, subcortical, retinal, uncertain) or posterior circulation.  If the 
participant was adjudicated to have had a TIA/mS, the likely mechanism was determined 
using the TOAST classification22  
Practice data  
Practice data collected included practice size (both individual and full-time-equivalent GP 
numbers), rurality/urbanicity index of the practice,23 after-hours care arrangements, practice 
GP staffing arrangements in the local hospital, and distance from the practice to the ANVC. 
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Hypotheses 
1. That the majority of TIA/mS patients in the Hunter region are managed exclusively in 
primary care. 
2. That rural dwelling, lower socio-economic status and advancing age will be associated 
with lower rates of referral to specialist care. 
3. That specialist care will demonstrate greater adherence to guideline-recommended 
investigation and management in comparison to exclusive GP management specifically 
for: 
a) Brain imaging 
 b) Vascular imaging 
 c) Immediate anti-platelet, blood pressure and statin therapy 
4. That referral to specialist care will result in lower recurrent vascular event rates. 
5. That referral to specialist care will result in greater quality of life 
6. That rates of recurrent vascular events will be lower than those in the international 
cohorts  
7. That rates of recurrent vascular events will be higher in lower SES bands. 
8. That the processes of care (time from event to presentation, time from presentation to 
referral to secondary care, time to secondary care assessment) will be associated with -  
a) Risk stratum (ABCD2); b) Patient factors (age, SES status, risk factors and co-
morbidities); c) Practice factors (geographical location, size of practice, out-of-hours care 
arrangements) 
Outcome measures 
Process and clinical outcomes were determined. 
a) Process measures 
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 Whether a patient was referred for secondary care or was managed entirely in general 
practice. 
 Time from event to first presentation to a health professional. 
 For participants referred to the ANVC: time from event to clinic ANVC appointment. This 
composite outcome entails other study outcomes - time from first patient presentation to 
referral to the ANVC, time from event to referral, time from referral to ANVC 
appointment. 
 Time from event to receiving brain imaging, vascular imaging and prescriptions of anti-
platelet, anti-coagulant, antihypertensive and statin medications. 
 
b) Clinical outcomes 
 Recurrent stroke and major vascular events were ascertained via: 
o Diagnosis by stroke physicians (in ANVC attendees). 
o Research nurse phone interviews with participants at baseline, 3, 6 and 12 
months 
o Research nurse examination of GP clinical records of consenting participants 
at baseline and 12 months. 
o General practice records including imaging findings. 
o Cross-referencing with the Hunter Region Heart and Stroke Register.24 
 Health Related Quality of Life  
 Disability 
 Depression and anxiety 
 Cognitive status 
 Fatigue 
(see Appendix 4 for details of instruments to be used) 
The primary outcomes were  
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1) Whether a patient was referred for secondary care or was managed entirely in 
general practice 
2) Recurrent stroke and major vascular events 
 
Analyses and sample size calculations 
The Hunter region population in 2011 was 620,530.11 For reference, the OXVASC study is 
conducted across a population of 91,000 individuals registered with nine Oxfordshire general 
practices and 63 GPs.  The OXVASC catchment ascertains approximately 100 neurologist-
adjudicated TIA and 100 minor stroke cases per annum.4,20,25,26 In the Hunter region, with a 
ratio of population to Full-Time Equivalent (FTE) GPs of 1500:1, and allowing for a 
participation response rate of 60%, we needed to recruit practices containing approximately  
51 FTE GPs to recruit 100 TIA/mS per year (and, thus 400 TIA/mS during the study period).  
See Appendix 5 for planned analytical methods and associated sample size calculations. 
Funding. 
InSIST is funded by NHMRC Project Grant ID 1027794 
Summary and conclusions 
InSIST is an inception cohort study addressing the interactions of TIA/mS patients with 
health care systems, including the primary-secondary care interface, and the outcomes of 
TIA/mS in a community-based sample. It compares processes of care and outcomes in three 
countries and provides data on which to base context-appropriate TIA/mS management 
guidelines for Australian practice. 
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